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Abstract
TOR kinases integrate environmental and nutritional signals to regulate cell growth in eukaryotic organisms. Here, we describe
results from a study combining quantitative proteomics and comparative expression analysis in the budding yeast, S. cerevisiae,
to gain insights into TOR function and regulation. We profiled protein abundance changes under conditions of TOR inhibition
by rapamycin treatment, and compared this data to existing expression information for corresponding gene products
measured under a variety of conditions in yeast. Among proteins showing abundance changes upon rapamycin treatment,
almost 90% of them demonstrated homodirectional (i.e., in similar direction) transcriptomic changes under conditions of heat/
oxidative stress. Because the known downstream responses regulated by Tor1/2 did not fully explain the extent of overlap
betweenthesetwo conditions, wetestedfor novel connections between the major regulators of heat/oxidativestress response
and the TOR pathway. Specifically, we hypothesized that activation of regulator(s) of heat/oxidative stress responses
phenocopied TOR inhibition and sought to identify these putative TOR inhibitor(s). Among the stress regulators tested, we
foundthatcells(hsf1-R206S,F256Sandssa1-3ssa2-2)constitutivelyactivatedforheatshocktranscriptionfactor1,Hsf1,inhibited
rapamycin resistance. Further analysis of the hsf1-R206S, F256S allele revealed that these cells also displayed multiple
phenotypes consistent with reduced TOR signaling. Among the multiple Hsf1 targets elevated in hsf1-R206S, F256S cells,
deletion of PIR3 and YRO2 suppressed the TOR-regulated phenotypes. In contrast to our observations in cells activated for Hsf1,
constitutive activation of other regulators of heat/oxidative stress responses, such as Msn2/4 and Hyr1, did not inhibit TOR
signaling. Thus, we propose that activated Hsf1 inhibits rapamycin resistance and TOR signaling via elevated expression of
specific target genes in S. cerevisiae. Additionally, these results highlight the value of comparative expression analyses between
large-scale proteomic and transcriptomic datasets to reveal new regulatory connections.
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Introduction
Understanding how organisms respond to multiple environ-
mental cues to adjust cellular growth and organismal development
has been a long standing aim of biology. Recent work has revealed
that the TOR (Target Of Rapamycin) kinases play an evolution-
arily conserved central role in this integration (for recent reviews,
see [1–3]). The TOR proteins are members of the phosphatidy-
linositol kinase (PIK) family of kinases. Unicellular fungi such as S.
cerevisiae harbor two homologous TOR genes, Tor1 and Tor2,
whereas higher organisms contain only one TOR gene. Much of
our understanding of the TOR kinases has come from use of the
bacterially derived drug, rapamycin, which specifically inhibits one
of the two TOR kinase complexes, TORC1. Owing to the role of
TORC1 complex in regulation of cell growth and the specificity of
rapamycin, the drug (or its derivatives) is currently used in
antirestenosis, antifungal, and immunosuppresant treatments in
humans. TOR kinases also exist in a distinct TORC2 complex
which has been implicated in the spatial control of cellular growth
[4,5].
Microarray analyses in yeast and human cells have demonstrated
dramatic effects of rapamycin on gene expression [6–10]. Even
though it is generally accepted that correlation between mRNA and
protein levels is not always linear [11,12], quantitative proteomic
profiling of rapamycin treatment has not been done in any organism
to date. In the case of a highly studied organism like the budding
yeast, S. cerevisiae, microarray expression data for the entire genome
under a variety of perturbations is available [13], and several global
rapamycin fitness screens have been carried out [14–17]. Integration
of these diverse datasets with the rapamycin-induced proteomic
expression profile could potentially provide new insights into
regulatory pathways that intersect with TOR signaling.
With the aim of gaining new insights into TOR function and
regulation, we have performed quantitative proteomic profiling of
yeast cells treated with rapamycin, in combination with compar-
ative expression analysis of this data with existing microarray data
PLoS ONE | www.plosone.org 1 February 2008 | Volume 3 | Issue 2 | e1598in S cerevisiae. Of the proteins identified whose steady-state levels
changed upon rapamycin treatment, we observed that a large
majority of their corresponding mRNA transcripts also undergo a
similar change under conditions of heat/oxidative stress. Because
the known responses regulated by TOR did not fully explain this
overlap, we hypothesized that activation of stress regulator(s)
phenocopied TOR inhibition. Testing this hypothesis using
genetic analysis, we found that constitutive activation of the
conserved stress regulator Hsf1 confers rapamycin sensitivity and
reduced TOR signaling via elevated expression of Hsf1 target
genes. These findings identify Hsf1 as a putative inhibitor of TOR
signaling and provide new insights into the relationship between
stress signals and the inhibition of cell growth.
Results
Quantitative proteomics reveals changes in protein
abundance induced by rapamycin treatment
In this report, we describe results from a strategy combining
quantitative proteomics and comparative expression analysis to
obtain insights into TOR function and regulation in the budding
yeast, S. cerevisiae. For the first step in this strategy, we profiled
protein abundance changes in yeast cells treated with rapamycin, a
highly specific inhibitor of Tor1/2 [18,19]. Figure 1A outlines the
quantitative proteomics method used. To limit protein degrada-
tion, the protease deficient strain, BJ5465 was used. Similar to
other yeast strains [20–22], growth of BJ5465 slowed ,70 minutes
after treatment with 200 nM rapamycin (data not shown).
Rapamycin-treated, and untreated cells were collected at this
time point, and total protein isolated from each sample. 300 mg
protein from each sample was digested with trypsin, and the
separate peptide mixtures differentially labeled at their n-termini
using
12C6 (‘light’) and
13C6 (‘heavy’) versions of phenyl isocyanate
(PIC) [23]. Peptides from the rapamycin treated sample were
labeled with
13C6-PIC, while those from the non-rapamycin
treated sample (methanol alone) with
12C6-PIC (Figure 1A).
Combined samples were fractionated by preparative isoelectric
focusing using Free Flow Electrophoresis (FFE) as described [24],
and the peptide fractions analyzed by mLC-MS/MS on a linear
ion trap instrument.
Using a combination of probability assignments and filtering
based upon peptide pI, as we have previously described [24], we
obtained a high confidence catalogue of 578 proteins (false positive
rate ,1%). Relative abundance ratios of each identified peptide,
measured by the ratios of
13Ct o
12C signal intensities for each
peptide, were obtained by manual examination of MS data. Based
upon the average calculated abundance ratios across the entire
protein catalogue, we determined that 1.5-fold and greater relative
abundance changes were significant, as these ratios differed by
over three standard deviations from the average protein ratio for
the entire dataset. Using this significance threshold, 127 proteins
(82 up-regulated, 45 down-regulated) representing a broad array
of cellular functions showed changes in abundance. These proteins
were grouped into functional categories using the ‘gene ontology’
function available on the yeast genome website (www.yeastgen-
ome.org). The functional profile of rapamycin-affected proteins is
shown in Figure 1B, and supporting mass spectrometric data and
quantitative information are shown for all proteins in supplemen-
tary information (Table S1).
We first compared our proteomic dataset to data from previous
microarray studies measuring transcriptional changes due to
rapamycin treatment in yeast [6,7]. We assumed that at least
some of the abundance changes measured for specific proteins
should be affected in a similar (i.e. homodirectional) manner in
these studies. Among the 127 proteins which changed in
abundance in our proteomic analysis, 102 also showed a
homodirectional change in their corresponding mRNA transcripts
(see Figure 1C). This high level of correlation between protein
and mRNA behavior was observed in spite of the fact that
microarray studies used for comparison were done using yeast
from a different strain background (BY4741) than ours (BJ5465),
and using different rapamycin treatment conditions (100 nM
rapamycin either for 30 minutes [7] or over a time course up to
120 minutes [6]). This result may not be unexpected, however,
given that rapamycin induced transcriptomic and translational
state changes are positively coupled in yeast [21].
Almost half of the 45 total proteins showing a decrease in
abundance in our dataset were either ribosomal proteins (RPs) or
other translational components (See supplementary information,
Table S2). This result is consistent with the well known role of
TOR kinases in ribosomal biogenesis and protein translation
[6,20,25–27]. With the exception of Pre10, Acs2, and Ppt1 (no
mRNA expression data in presence of rapamycin is currently
available for these), all of the proteins that decreased in abundance
due to rapamycin treatment also showed decreased mRNA
abundance in previous microarray analyses of rapamycin
treatment [6,7].
Consistent with the well-known role of TOR signaling in the
regulation of metabolism, majority of proteins that increased in
abundance upon rapamycin treatment fall into this general
functional category (See Table S2). These proteins are involved
in diverse aspects of metabolism, including amino-acid, carbohy-
drate, and nucleic acid metabolism. Several of these proteins
regulate adaptation to poor nitrogen sources (proline, urea,
allantoin) or carbon starvation. A majority of up-regulated
proteins are also known to be affected at the mRNA level in a
homodirectional manner (based on comparison with microarray
data generated previously; [6,7]).
Although the majority of the proteins show homodirectional
changes with their mRNA transcripts upon rapamycin treatment,
abundance changes of 17 proteins did not correlate with their
mRNA transcripts. These proteins represent gene product
responses to rapamycin treatment which could not have been
predicted using microaray studies alone. Of these, five were
actually anti-correlated (decreased in abundance at the mRNA
level based on microarray experiments, but increased at the
protein level; see Figure 1C). These anti- and non-correlated
proteins and their magnitude of abundance increase were: Bmh1
(1.8 fold), Inh1 (2.2 fold), Qcr7 (1.6 fold), Ham1 (2.1 fold), Sbp1
(2.5 fold), Abf2 (27 fold), Crh1 (1.6 fold), Bgl2 (2.6 fold), Trr1 (1.9
fold), Pma1 (1.8 fold), Erv25 (1.6 fold), Cpr1 (1.7 fold), Pac10 (37
fold), YOL111C (3 fold), YLR301W (1.7 fold), Ppx1(52 fold), and
Gvp36 (2.2 fold). Independent validation of these novel proteomic
changes is necessary before experiments are designed based on
these findings.
Comparative expression analysis indicates a broad stress
response due to rapamycin treatment
Although the analysis of our proteomics data above confirmed
that our results were largely consistent with known effects of
rapamycin treatment in yeast, it provided only limited insights into
potential new pathways involved in regulation of TOR function.
Therefore, as a next analysis step, we compared our proteomic
profile of rapamycin treatment to existing expression data for
corresponding gene products measured under a variety of
conditions in yeast. We sought to identify conditions that resulted
in similar proteomic or transcriptomic responses to those observed
for rapamycin treatment, and use this information for obtaining
insights into TOR regulation. Given that few datasets exist of
Hsf1 and TOR signaling
PLoS ONE | www.plosone.org 2 February 2008 | Volume 3 | Issue 2 | e1598Figure 1. Proteomic analysis strategy and results. (A) Sample preparation workflow for quantitative proteomic analysis of rapamycin treatment
in BJ5465 yeast cells. (B) Functional categorization of 127 proteins showing abundance changes of 1.5 fold or greater due to rapamycin treatment.
The number of proteins from each category, and their relative percentages are also indicated on the pie chart. (C) Correlation or anticorrelation
(described as similar or opposite changes between proteins and RNA, respectively) for rapamycin affected proteins (obtained via proteomic analysis
in this study) and gene transcripts (obtained by microarray analysis of rapamycin treated yeast cells; *[6,7], and heatshock/oxidative stress; **[13]).
doi:10.1371/journal.pone.0001598.g001
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studied organism such as S. cerevisiae, we compared our dataset
with currently available transcriptomic information from yeast
exposed to a variety of environmental conditions [13]. This
comparison was done ‘qualitatively’- looking for gene products
which showed homodirectional changes (i.e. changed in the same
direction) in our proteomic dataset and in microarray experiments,
but not considering the magnitude of these changes in these
different datasets.
Our comparative expression analysis revealed that 88% of
proteins (112/127) showing an abundance change due to rapamycin
treatment also showed homodirectional change at the mRNA level
under conditions of heat/oxidative stress (Figure 1C). Based upon
previous studies, the notion of TOR inhibition by rapamycin
treatment activating a broad stress response inyeast is not surprising.
Indeed, rapamycin treatment in yeast is known to induce a general
stress response through the Msn2/4 transcription factor, resulting in
increased transcription of its target genes [28,29]. However, a closer
look at our proteomic dataset showed that a number of the proteins
affected by rapamycin treatment are not known targets of Msn2/4
[13,30,31]; these proteins also overlapped extensively between
rapamycin and heat/oxidative stress (ribosomal proteins, for
example). This suggested that involvement of additional regulatory
factors might better explain the extent of overlap in affected genes
under conditions of rapamycin treatment and heat/oxidative stress.
At least some of the proteins showing abundance changes due to
rapamycin treatment in our dataset are targets of other transcription
factors that are known to be regulated by the TOR pathway in yeast
[Gat1/Gln3, Rtg1/3, Crf1, Fhl1, and Spf1 [22,25,32,33]]. Howev-
er, little information exists to explain the similar abundance changes
observed for their transcriptional outputs under conditions of
rapamycin treatment and heat/oxidative stress. We also identified
the stress regulator Hyr1 [34] in our proteomic analysis, which
increased ,17-fold (see Table S2), which could at least partially
explain the extent of overlap between the two conditions. However,
the targets regulated by Hyr1 in yeast are not extensively
characterized, and thus its role in the observed overlap was not
easily explained.
Testing of the major regulators of stress response in
yeast suggests a novel role for Hsf1 activation in
inhibiting TOR/rapamycin resistance
The results of our comparative expression analysis suggested that
existing information could not fully explain the extent of overlap in
affected gene productsunder conditionsof rapamycin treatment and
heat/oxidative stress. This led us to investigate possible novel
connectionsbetweenstressregulatorsinyeastandtheTORpathway
to better explain our observations. Specifically, we hypothesized that
activation of regulator(s) of heat/oxidative stress response inhibits
TOR function and/or signaling. To test our hypothesis, we
investigated the effects of activation of the most well characterized,
stress regulators in yeast, Msn2/4 [13,35,36], Hyr1 [34], and Hsf1
[37–39], on rapamycin resistance and TOR signaling.
Initially, we tested heat shock transcription factor 1 (Hsf1) for a
possible role as a TOR inhibitor (for recent reviews on Hsf1, see
[40,41]). Hsf1 forms a homotrimer and recognizes heat shock
elements (HSEs) in promoters of target genes consisting of at least
three inverted repeats of nGAAn. Transcriptional targets of Hsf1
include molecular chaperones, heat shock proteins, and regulators
of protein degradation/homeostasis, and are involved in regulat-
ing diverse signal transduction pathways as well as housekeeping
functions within the cell [40–43].
To test for effects of Hsf1 activation on TOR signaling, we made
use of mutants that are constitutively activated for Hsf1. One of the
strains, hsf1-R206S, F256S, contains mutations in critical residues
within the DNA-binding domain of HSF1 [44]. The R206S and
F256S substitutions are located in the ‘turn’ region and the fourth
beta-sheet of the Hsf1 DNA-binding domain (DBD), respectively
[45–47].Importantly,these residuesare notlocated inthe third helix
region of Hsf1 (which binds the nGAAn sequence), or in the
trimerization domain of Hsf1, suggesting that these mutations would
not affect sequence specificity of Hsf1 or its trimerization,
respectively. The R206S substitution is expected to affect the
DBD-DBD interaction, and F256S affects the activator function of
Hsf1. The ability of hsf1-R206S, F256S cells to behave as a HSF1
gain-of-function mutant is described in the next section. We also
made us of ssa1-3 ssa2-2 cells, which have been previously shown to
be constitutively activated for Hsf1 because of the inability of
mutated Ssa1/2 to autoregulate and inhibit Hsf1 function [48-50].
Consistent with reduced TOR signaling upon Hsf1 activation,
hsf1-R206S, F256S cells were hypersensitive to rapamycin
treatment at 25uC( Figure 2A). Cells with reduced TOR signaling
are hypersensitive to rapamycin [14,20]. In contrast, hsf1-F256S
Figure 2. Cells with increased Hsf1 transcriptional activity are
hypersensitive to rapamycin treatment. (A) Rapamycin sensitivity
of HSF1, hsf1-R206S, F256S, and hsf1-R256S cells (upper panel). FPR1-
dependent rapamycin sensitivity of hsf1-R206S, F256S cells (lower
panel). (B) Rapamycin sensitivity of SSA1 SSA2, ssa1-3 ssa2-2, and ssa1-3
ssa2-2 hsf1P215Q cells. Cells were grown to saturation at 25uC and serial
dilutions (50,000, 5000, and 500 cells per spot) were spotted on YPD
plates supplemented with 25 nM rapamycin or drug carrier solvent
(methanol) and assayed for growth at 25uC for the indicated durations
of time. ssa1-3 ssa2-2 cells and derivatives were grown identically but
spotted at a density of 5000 and 500 cells/spot.
doi:10.1371/journal.pone.0001598.g002
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unaffected under the same conditions, indicating that dysregula-
tion (i.e., qualitative change in function) of HSF1 was not sufficient
to cause rapamycin sensitivity (Figure 2A, upper panel).
Furthermore, the rapamycin sensitivity of hsf1-R206S, F256S cells
was completely suppressible by a deletion of the FPR1 gene
(Figure 2A, lower panel) indicating that these cells were
hypersensitive to TOR inhibition specifically [18,19]. Additional-
ly, hsf1-R206S, F256S cells did not show sensitivity towards low
doses of cycloheximide, arguing against a general drug-sensitivity
of this mutant (data not shown).
As an independent means to assess the effect of Hsf1 activation
on rapamycin sensitivity, we also assayed ssa1-3 ssa2-2 cells for
growth in the presence of rapamycin. As shown in Figure 2B,
these cells were also hypersensitive to rapamycin treatment at
25uC. Importantly, decreasing Hsf1 function in these cells by an
hsf1P215Q mutation [49,51] suppressed their rapamycin sensitivity
significantly, demonstrating that the rapamycin sensitivity of ssa1-3
ssa2-2 cells was dependent on Hsf1 activation. In contrast to our
observations in cells with constitutively active Hsf1, hypomorphic
or dysregulated alleles of hsf1 (HSF1/hsf1D, hsf1-ba1, hsf1-AR1,
hsf1-N583, or hsf1-F256S; [47,52–54]) were essentially unaffected
for rapamycin resistance (data not shown), suggesting the basal
function of Hsf1 or its dysregulation does not affect rapamycin
resistance/TOR signaling in S. cerevisiae.
hsf1-R206S, F256S mutant cells have increased activity of
Hsf1 in a temperature-sensitive manner
We further investigated the effect of the R206S, F256S mutation
on Hsf1 activity at a variety of temperatures. The hsf1-R206S,
F256S mutation has been recently demonstrated to have a severe
defect in the expression of multiple Hsf1 targets under heat shock
conditions [44]. Consistent with this result, these cells displayed
dramatically reduced transcriptional activity at 33uC against the
HSE4Ptt-CYC1-LacZ reporter (Figure 3A). However, at 29uC,
their activity was roughly comparable to wild type cells and at
25uC, hsf1-R206S, F256S cells had a 2-fold increase in transcrip-
tional activity (Figure 3A). Thus, hsf1-R206S, F256S cells have
enhanced basal activation of Hsf1 at 25uC towards a synthetic
reporter of Hsf1 activity.
To further confirm that hsf1-R206S, F256S cells had enhanced
basal activation of Hsf1 at 25uC, we tested the expression level of
numerous known transcriptional targets of Hsf1 in these cells. Hsf1
targets have been classified into those that contain either ‘perfect’
heat shock elements (HSEs) or those that contain discontinuous
heat shock elements (‘gap’ type and ‘step’ type) [44]. As shown in
Figure 3B, Hsf1 targets with ‘step’ type HSEs (HSP12), or perfect
HSEs (SSA3/4, HSP42, and HSP78), were increased dramatically
for expression in these cells at 25uC compared to wild-type,
whereas CUP1-1 (which has ‘gap’ type HSEs) was nearly
unaffected for expression under these conditions. Hsf1 targets
without consensus heat shock elements in their promoter elements
(identified by global CHIP-on-CHIP analysis [55]), such as PIR3,
and YRO2, were also increased in expression in these cells. These
results led us to conclude that hsf1-R206S, F256S cells largely
behave as an hsf1 gain-of-function mutant at 25uC. Our
observation is in agreement with previous reports demonstrating
that mutation of the same residues in Hsf1 with different amino
acid substitutions (R206S, F256Y vs. R206S, F256S) also enhanced
basal transcriptional activity of Hsf1 2–3 fold (using a synthetic
reporter of Hsf1 activity [56]). Consistent with our findings for the
hsf1-R206S, F256S cells, hsf1-R206S, F256Y cells were also found
to be hypersensitive to rapamycin treatment (data not shown).
hsf1-R206S, F256S cells display reduced TOR signaling
Given our results showing FPR1-dependent rapamycin sensi-
tivity of hsf1-R206S, F256S cells, we tested for effects on Tor1/2
protein levels and TOR signaling. We found that hsf1-R206S,
F256S cells did not show decreased Tor1 and Tor2 protein levels
compared to wild type cells, as assessed by western blotting (data
not shown). Hence, we tested for effects on TOR signaling in hsf1-
R206S, F256S cells.
In yeast, activated Tor1/2 complex inhibits the expression of
genes involved in stress pathways, autophagy, metabolite accumu-
lation (glycogen synthesis), retrograde signaling and Nitrogen
Catabolite Repression (NCR) pathways, while it promotes expres-
Figure 3. Effect of hsf1-R206S, F256S mutation on expression of
HSE4Ptt-CYC1-LacZ reporter and Hsf1 target genes. (A) hsf1-R206S,
F256Sand isogenic HSF1cellstransformedwithHSE4Ptt-CYC1-lacZ plasmid
[53] were grown overnight in minimal selective media at 23uCt oa nO D 600
of 0.5 units, and then shifted to 25uC, 29uC, or33uC, for 90 minutes prior to
determination of b-galactosidase activity. (B) mRNA levels of diverse
classes of Hsf1 targets in hsf1-R206S, F256S cells relative to HSF1 cells. The
promoter region of HSP12 is known to have ‘step’ heat shock elements
(HSEs), while that of SSA3/4, HSP78,a n dHSP42 have perfect HSEs [44].
Although canonical HSEs have not been found in promoter regions of PIR3
and YRO2, these were identified in global CHIP-on-CHIP experiments as
Hsf1 targets [55]. CUP1-1 has a variant HSE [44]. Cells were grown at 25uC,
and processed for RNA isolation, real-time PCR analysis, and analyzed as
described in materials and methods section. Relative expression of each
gene was normalized to actin and expressed as an average fold induction
in hsf1-R206S, F256S cells versus unperturbed wild type cells.
doi:10.1371/journal.pone.0001598.g003
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regulators ([1–3] and references therein). We utilized quantitative
real-time PCR tomonitorexpression levelsof representativegenesof
each of these TORC1-regulated pathways as an initial ‘readout’ of
TOR signaling. As expected, rapamycin treatment in HSF1 cells,
caused elevated expression of genes from each of the TOR-inhibited
pathways, and reduced expression of ribosomal protein (RP genes)
(see Figures 4A and 4B, left panels).
Consistent with reduced TOR signaling, hsf1-R206S, F256S cells
exhibited elevated expression of genes from each of the TOR-
inhibited pathways (see Figure 4A, right panel). The affected genes
include the Msn2/4 target gene, CTT1[36,57] (increased 4.9-fold),
the NCR gene, PUT1 [58,59] (increased 6.3 fold) and the Rtg1/2
target gene, CIT2 [58,59] (increased 2.7-fold). Additionally, the
regulator of the last step in glycogen synthesis, GSY1/2, known to be
induced upon TOR inhibition [20,28,60], increased 4.2-fold. The
autophagic marker Atg8/Aut7 [61], increased 5.4-fold. Also, we
found reduced expression of ribosomal protein genes and their
positive regulators, such as RAP1,i nhsf1-R206S, F256S cells (see
Figure 4B, right panel). Thus the expression profile of multiple
TOR-regulated genes is consistent with reduced TOR signaling in
hsf1-R206S, F256S cells.
As further evidence for reduced TORC1 function in hsf1-
R206S, F256S cells, we assayed Gln3p mobility/phosphorylation,
Figure 4. Reduced TOR signaling in hsf1-R206S, F256S cells. (A) Expression level of genes representing five different pathways repressed by
TOR function, upon rapamycin treatment in HSF1 cells (left panel), and in hsf1-R206S, F256S cells (right panel, in absence of rapamycin treatment). (B)
Expression level of ribosomal protein (RP) genes and RAP1, a positive regulator of RP genes, upon rapamycin treatment in HSF1 cells (left panel) and
in hsf1-R206S, F256S cells (right panel, in absence of rapamycin treatment) (C) Mobility of Gln3-myc13 in HSF1 cells treated with or without rapamycin
and hsf1-R206S, F256S cells with or without rapamycin treatment as indicated above. Cells were grown to log-phase at 25uC and treated with 200nM
rapamycin or methanol alone and processed for RNA isolation or total protein extraction as described in materials and methods section.
doi:10.1371/journal.pone.0001598.g004
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kinase in yeast cells [29,62]. TOR kinase activity promotes
phosphorylation of Gln3, while rapamycin treatment results in its
dephosphorylation. De-phosphorylated Gln3p runs faster on an
SDS-PAGE gel compared to its phosphorylated counterpart
([29,62], Figure 4C). Consistent with reduced Gln3 phosphoryla-
tion (and reduced TOR function), Gln3-myc13pr u n sf a s t e ri nhsf1-
R206S, F256S cells compared to HSF1 cells (see Figure 4C,l e f t
panel). Mobility of this faster migrating form of Gln3-myc13pi s
enhanced further by rapamycin treatment in hsf1-R206S, F256S cells
suggesting an intermediate effect on Gln3 phosphorylation (when
compared to rapamycin treatment, Figure 4C, right panel). This
result is in good agreement with the expression analysis of TORC1
regulated genes (See Figures 4A and 4B) which also showed a less
dramatic effect on TOR functional ‘readouts’ in hsf1-R206S, F256S
cells than rapamycin treatment of HSF1 cells.
Msn2/4 and Gln3 are necessary for full induction of TOR-
repressed genes in hsf1-R206S, F256S cells
Inhibiting TORC1 function (by rapamycin treatment for
example) causes nuclear localization/activation of multiple
transcription factors, including Msn2/4, and Gat1/Gln3, and
elevated expression of their target genes [22,29,32,63]. Thus, if
hsf1-R206S, F256S cells have reduced TOR function, then the
elevated expression of TORC1-inhibited genes (some of which are
shown in Figure 4A) should be dependent on Msn2/4 and Gat1/
Gln3. To test this hypothesis, we analyzed effects of their deletion
in hsf1-R206S, F256S cells.
Upon deletion of MSN2 and MSN4, elevated expression of its
target genes CTT1, GSY1/2 and ATG8 (all of which have Msn2/4
binding sites in their promoter elements), but not CIT2 (target of
Rtg1/3), was reduced in hsf1-R206S, F256S cells (see Figure 5A).
Elevated expression of CTT1 in particular, was completely
abolished. Although MSN2,4 deletion suppresses expression of
GSY1/2 and ATG8 only partially, this likely does not indicate a
direct activating effect of the variant hsf1-R206S, F256S protein on
Msn2,4 target genes, as similar results were also observed in
rapamycin treated HSF1 msn2Dmsn4D cells (see Figure 5B). As
shown in Figure 5C, deletion of both GLN3 and GAT1 abrogated
expression of multiple NCR genes (GAP1, PUT1, DAL80), but not
CTT1 (which is Msn2/4 dependent instead), in hsf1-R206S, F256S
cells (see Figure 5C). Furthermore, combining hsf1-R206S, F256S
cells with msn2Dmsn4D or gln3Dgat1D suppresses the rapamycin
sensitivity of hsf1-R206S, F256S cells; however, the effect of
msn2Dmsn4D is very modest when compared to gln3Dgat1D (see
Figure 5D). Taken together, these results provide genetic
evidence for activation of TORC1-inhibited transcription factors
in hsf1-R206S, F256S cells.
Elevated expression of PIR3 and YRO2 inhibits rapamycin
resistance and TOR signaling in hsf1-R206S, F256S cells
To explain the observed effects on TOR-regulated signaling in
hsf1-R206S, F256S cells, we considered the possibility that elevated
expression of select Hsf1 targets might contribute to these
phenotypes. A number of Hsf1 target genes that were elevated
for expression in these cells (HSP12, HSP30, HSP42, HSP78, SSA4,
HSP104, PIR3 and YRO2, see Figure 3B) were deleted in hsf1-
R206S, F256S cells, and tested for effects on rapamycin sensitivity.
Most of the deletions had essentially no effect on the rapamycin
sensitivity of hsf1-R206S, F256S cells (data not shown). However,
as shown in Figure 6A, deletion of YRO2 partially suppressed the
rapamycin sensitivity of hsf1-R206S, F256S cells at 10 nM
rapamycin, and deletion of PIR3 suppressed strongly the
rapamycin sensitivity of these cells at both 10 nM and 25 nM
rapamycin. Importantly, deletion of these genes had no effect on
the rapamycin sensitivity of wild type cells, indicating that their
basal expression level did not inhibit rapamycin resistance.
PIR3 is a heat inducible, glycosylated protein that is a structural
component of the yeast cell wall, and required for tolerance of
yeast to heat shock and osmotin [13,64,65]. YRO2 is a gene of
unknown function that is also heat inducible, localized to the cell
periphery and bud, in particular to the cell membrane and
mitochondria [13,66–68]. Although neither of these genes have
well defined heat shock elements in their promoter regions, these
genes were previously identified as Hsf1 targets in a global CHIP-
on-CHIP analysis [55].
Given that PIR3 was a strong suppressor of the rapamycin
sensitivity of hsf1-R206S, F256S cells, we tested if its deletion might
also augment TOR signaling in these cells. Supporting this notion,
expression levels of diverse TOR-inhibited genes (CTT1, CIT2,
PUT1, GSY1/2,a n dATG8; see Figure 6B), was each reduced upon
PIR3 deletion in hsf1-R206S, F256S cells. Additionally, expression of
multiple RP genes was also augmented partially in hsf1-R206S,
F256S cells by PIR3 deletion (see supplementary information;
Figure S1). PIR3 or YRO2 deletion did not suppress the
temperature-sensitivity of hsf1-R206S, F256S cells indicating speci-
ficity towards TOR-related phenotypes of these cells (Figure 6C).
Taken together,theseresults demonstrate that elevated expression of
specific Hsf1 target genes inhibits rapamycin resistance and TOR
signaling in hsf1-R206S, F256S cells.
Consitutive activation of Msn2/4 or Hyr1 does not inhibit
TOR signaling
Having shown that cells with constitutively active Hsf1 display
reduced TOR signaling, we then asked if cells activated for
additional heat/oxidative stress induced transcription factors also
displayed similar phenotypes (to test if this observation was unique
to Hsf1). Towards this aim, we tested if overexpression of MSN2,
MSN4 or HYR1 might also inhibit TOR signaling (similar to what
was seen upon HSF1 activation). Overexpression of each of these
genes was achieved by 2m plasmids previously used by others
[69,70] and verified by real-time PCR (data not shown).
As shown in Figure 7A, overexpression of MSN4 or HYR1 was
not sufficient to cause rapamycin sensitivity, arguing against the
notion that these genes could act as putative TOR inhibitors.
Interestingly, MSN2 overexpression did confer rapamycin sensi-
tivity (Figure 7A). However, this sensitivity was not accompanied
by attenuated TOR signaling as assessed by expression analysis of
TORC1-regulated genes (See Figure 7B). These results point
instead to the possibility that overexpression of Msn2 targets
inhibits rapamycin sensitivity due to elevated expression of some of
its target genes, and that these do not inhibit TOR signaling akin
to Hsf1 target genes. Indeed, MSN2 overexpression caused a
dramatic increase in expression of its target gene, CTT1 (when
compared to the increase due to rapamycin treatment, see
Figure 7C). Collectively, these results further support a novel
role for activated Hsf1 among the stress activated transcription
factors in putatively inhibiting TOR signaling via elevated
expression of its target genes.
Discussion
In this study, we have performed the first proteomic profiling of
rapamycin treatment in S. cerevisiae, and used this information for
comparative expression analysis with existing expression data
measured under different conditions. Our aim was to use this
information for identifying novel relationships between regulators
Hsf1 and TOR signaling
PLoS ONE | www.plosone.org 7 February 2008 | Volume 3 | Issue 2 | e1598Figure 5. Role of Msn2/4 and Gln3/Gat1 in TOR-regulated phenotypes seen in hsf1-R206S, F256S cells. (A) Effect of deleting MSN2, 4 on
elevated expression of Msn2/4 targets in hsf1-R206S, F256S cells (B) Effect of deleting MSN2, 4 on rapamycin induced expression of Msn2/4 targets in
HSF1 cells (C) Effect of deleting GLN3 alone or both GLN3 and GAT1 on elevated expression of NCR genes in hsf1-R206S, F256S cells (D) Effect of MSN2/
4, GLN3/GAT1,o rHYR1 deletions on rapamycin sensitivity of hsf1-R206S, F256S cells. Relative expression of each gene was normalized to actin and
expressed as an average fold induction relative to wild type cells.
doi:10.1371/journal.pone.0001598.g005
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also sought to identify protein abundance changes that could not
be predicted from previous microarray analyses of rapamycin
treatment [6,7] to gain new insights into TOR function. Although
the total number of proteins identified with high confidence (578)
was relatively small compared to other proteomic studies in yeast,
(most likely due to the charge-neutralizing effect on peptide n-
termini of the PIC label incorporated for quantitative analysis
Figure 6. Deletion of Hsf1 target genes, PIR3 and YRO2 partially
suppress TOR-regulated phenotypes of hsf1-R206S, F256S cells.
A) Suppression of rapamycin sensitivity of hsf1-R206S, F256S cells by
deletion of PIR3 and YRO2. HSF1 and hsf1-R206S, F256S cells bearing the
indicated gene deletions were grown to saturation at 25uC and 5000
cells each were spotted on YPD plates supplemented with methanol
alone (rapamycin solvent), 10 nM, and 25 nM rapamycin, respectively.
B) PIR3 deletion reduced expression of multiple TOR-repressed genes in
hsf1-R206S, F256S cells. Expression level of genes was monitored by RT-
PCR as explained in materials and methods section. C) Effect of PIR3 and
YRO2 deletion on temperature sensitivity of hsf1-R206S, F256S cells.
Indicated strains were streaked out on YPD plates and allowed to grow
3 days at 34uC.
doi:10.1371/journal.pone.0001598.g006
Figure 7. Over expression of MSN2, MSN4 or HYR1 does not
inhibit TOR signaling (A) Effect of over expression of MSN2,
MSN4 or HYR1 on rapamycin resistance of wild type cells. Wild
type HS170T cells (HSF1 cells isogenic to hsf1-R206S, F256S cells used in
this study) were transformed with 2m plasmids for over expression of
the relevant genes, and spotted on selective media supplemented with
25 nM Rapamycin (or methanol) at 50,000, 5000, and 500 cells per spot
and assayed for growth at 25uC (B) Effect of MSN2 over expression on
TOR signaling ‘readouts’ assayed by real-time PCR (C) Effect of MSN2
over expression versus rapamycin treatment, on expression level of
CTT1, a classical Msn2 target gene. RNA isolation, cDNA synthesis, real-
time PCR conditions, and analysis of data are described in materials and
methods section.
doi:10.1371/journal.pone.0001598.g007
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upon rapamycin treatment. Among these, 17 proteins were found
increased inabundance upon rapamycin treatment that do not show
similar changes in their corresponding mRNA transcripts. Among
these, increased abundance of Ppx1 and Inh1 upon rapamycin
treatment is of particular interest, since Ppx1 overexpression
inhibited mTOR activity in mammalian cells [71], whereas inh1D
cells were reportedly rapamycin resistant [16]. Our proteomic
findings thus suggest that the induction of these proteins might
potentiate TOR inhibition and promote rapamycin sensitivity in
yeast, although further study is necessary to confirm this possibility.
Using comparative expression analysis of our proteomic dataset
and existing microarray gene expression data, we observed
extensive overlap in gene products affected by rapamycin
treatment and conditions of heat/oxidative stress. Although the
activation of stress genes by rapamycin treatment has been noted
by other groups previously, it has been attributed mostly to the
activation of Msn2/4 under these conditions [6,29]. However, a
majority of the affected proteins we identified are not known to be
regulated by Msn2/4. Additionally, little information currently
exists about the other known downstream responses of TOR
inhibition to explain the extent of overlap observed between
rapamycin treatment and heat/oxidative stress. Preiss et al [21]
have demonstrated that rapamycin and heat shock induced
changes in the transcriptome are amplified at the translational
level. However, to the best of our knowledge a direct comparison
of the specific genes affected under each of these conditions, as
done here has not been reported previously.
Based upon the results of our comparative expression analysis,
we hypothesized that the activation of a regulator(s) of heat shock/
oxidative stress response inhibits TOR function and/or signaling.
Because these stress responses in yeast are controlled by three
main transcription factors, Msn2/4 [13,35,36], Hyr1 [34], and
Hsf1 [37–39], we explicitly tested for a putative role of their
activation in the inhibition of TOR signaling and rapamycin
resistance. Unlike other transcription factors tested, Hsf1 is unique
since cells constitutively activated for Hsf1 (hsf1-R206S, F256S
cells) specifically display multiple phenotypes consistent with
reduced TOR function. Several lines of evidence support this
conclusion. First, genes representing five different biological
functions (Stress genes, RTG signaling, NCR genes, Glycogen
synthesis, and Autophagy) which are inhibited by Tor1/2 in yeast,
are all elevated for expression in hsf1-R206S, F256S cells. Second,
multiple ribosomal protein genes (which are known to be down-
regulated upon TOR inhibition) are also reduced for expression in
hsf1-R206S, F256S cells. Third, western blotting indicates a faster
migrating form of Gln3p in these cells, consistent with reduced
phosphorylation of this physiological substrate of TORC1. Fourth,
genetic data support that the TORC1 inhibited transcription
factors, Msn2/4 and Gln3/Gat1 are activated in hsf1-R206S,
F256S cells. Finally, hsf1-R206S, F256S cells are hypersensitive to
rapamycin treatment in an FPR1-dependent manner, indicating
sensitivity to TOR inhibition.
Elevated expression of specific Hsf1 target genes in hsf1-R206S,
F256S cells contributes to the TOR-regulated phenotypes seen in
these cells. This conclusion is based on our finding that deletion of
PIR3 and YRO2 suppresses rapamycin sensitivity and PIR3
deletion also augments TOR signaling in hsf1-R206S, F256S cells.
In contrast, their deletion has no effect in wild-type cells (where
their expression is baseline compared to hsf1-R206S, F256S cells).
This also explains why PIR3 or YRO2 have not previously been
identified in global screens of rapamcyin fitness in yeast [14–16].
Also, neither of these genes have been identified in studies using
galactose-inducible overexpression of yeast genes to identify
regulators of rapamycin resistance [17]. Potential reasons for this
include the possibility that galactose-inducible library used by this
group did not express PIR3 and YRO2, or that their overexpression
does not inhibit rapamycin resistance on alternative carbon sources
such as galactose, or that they act in concert with other Hsf1 target
genes to affect TOR signaling and rapamycin resistance. Finally,
hypomorphic or dysregulated alleles of hsf1 were unaffected for
rapamycin resistance, further supporting a role for Hsf1 activation
induced targets specifically in inhibiting yeast TOR.
Additional work is necessary to determine the mechanism(s) by
which Hsf1 activation and the resultant elevated expression of
PIR3 and YRO2 putatively impinge on the TOR pathway. The cell
wall localization of Pir3 and integral membrane localization of the
7-membrane protein, Yro2, places them in proximity to the TOR
kinases which are membrane associated themselves [72,73]. It is
noteworthy that both TOR and Hsf1 function have been
previously implicated as being involved in aspects of cell wall
integrity via effects on the PKC/Mpk1 cascade [54,74,75], and
deletion of genes affecting cell wall integrity can affect rapamycin
resistance, and potentially TOR [16]. We found that several
putative rapamycin protective genes, were decreased for expres-
sion in hsf1-R206S, F256S cells; however, there was no effect of
PIR3 and YRO2 deletions on the reduced expression level of these
putative TOR regulators in hsf1-R206S, F256S cells (data not
shown). Thus, alterations in their expression levels are unlikely to
represent the basis of PIR3/YRO2 mediated effects in hsf1-R206S,
F256S cells.
In yeast, TOR signaling has been shown to bifurcate into at
least two distinct effector pathways regulated by Tap42/Sit4 and
Ras/cAMP/PKA [28]. While the former affects NCR gene
expression via Gln3/Gat1 activation, the latter regulates the effect
of the TOR pathway on RP gene expression and Msn2/4
activation. We have found that hsf1-R206S, F256S cells are
affected in both of these effector branches of TOR signaling, and
that PIR3 deletion suppresses ‘readouts’ of both effector branches.
Thus, we propose that Hsf1 activation and its target gene products
putatively act upstream of these TOR signaling effectors.
However, we cannot formally rule out the possibility that Hsf1
activation might also act parallel to the TOR pathway. Additional
targets of Hsf1 might play a role in this regulation as well. Further
work is necessary using a combination of genetic and transcrip-
tomic or proteomic analyses to identify the entire spectrum of Hsf1
targets involved, and determine their connections with the known
upstream regulators of the TOR pathway in yeast.
We have also tested for the effect of TOR inhibition on Hsf1
transcriptional activity. Cells expressing a plasmid borne synthetic
reporter of Hsf1 transcriptional activity (HSE-4Ptt-CYC1-LacZ)
were unaffected for LacZ expression either upon deletion of TOR1
or treatment with various concentrations of rapamycin (data not
shown). Additionally, only about 10% of the 165 known direct
targets of Hsf1 [55] are induced in microarray analyses of
rapamycin treatment, arguing against a general activation of Hsf1
[6,7]. Thus, unlike the stress regulators Msn2/4 and Hyr1, TOR
inhibition does not activate Hsf1 under these conditions.
Consistent with these results, dietary restriction (which can cause
TOR inhibition) in C. elegans does not significantly activate
expression from a reporter of Hsf1 activity (hsp-16.2:GFP, for
example) [76,77]. Rather, our results are consistent with Hsf1
activation inhibiting TOR signaling in yeast.
It would be interesting to test if a similar relationship between
Hsf1 and the TOR pathway existed in higher organisms as well.
Supporting such a possibility, activation of Hsf1 or TOR
inhibition promote lifespan in C. elegans [76,78,79]. However, the
effects of TOR depletion are independent of DAF-16 in C.elegans
Hsf1 and TOR signaling
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that Hsf1 activation promotes lifespan via a putative inhibitory
effect on the TOR pathway. Hsf1 activation or TOR inhibition
cause clearance of aggregation-prone proteins in higher organisms
[80–82], but it remains unknown if potential connections between
Hsf1 activation and mTOR exist and contribute to these
phenotypes. Arguing against such a possibility, we have found
that Celasterol treatment of Hela cells, (Celasterol causes
pharmacological activation of Hsf1 via an unknown mechanism
[83]), did not cause reduction in phosphorylation of the mTOR
subtrate, S6K protein (Bandhakavi S and Griffin TJ., unpublished
results). Future studies will shed further light on the possible
conservation of yeast Hsf1/TOR relationship in other organisms.
In conclusion, our findings provide intriguing new insights into
the relationship between stress signals and cellular growth
inhibition. Additionally, our results highlight the value of
performing comparative expression analysis between proteomic
and genomic datasets to reveal new regulatory connections.
Comparative expression analysis is often used in microarray-based
analyses of expression changes due to systematic perturbation to
find overlapping effects on biological pathways. However, it is
usually not an option in quantitative proteomic profiling based
studies because of the paucity of protein expression data obtained
under various experimental conditions. Our results show that a
qualitative comparison of proteomic and transcriptomic datasets,
looking for homodirectional changes between among gene
products common to these datasets, has value in identifying novel
regulatory connections. Such an approach takes advantage of the
wealth of microarray based studies that are currently available and
can therefore be a useful tool for enhancing the information
gained from proteomic profiling studies.
Materials and Methods
Strains and growth conditions
The protease deficient strain BJ5465 (MATa ura3-52 trp1 leu2-
delta1 his3-delta200 pep4::HIS3 prb1-delta1.6R can1 GAL) was
obtained from ATCC, and used for protein extraction following
rapamycin treatment. Cells expressing wild type or mutant HSF1
(HSF1, hsf1-R206S,F256S, hsf1-ba1, hsf1-AR1D, hsf1-N583, and
hsf1-R256S) and the isogenic version of msn2Dmsn4D were
obtained from Dr. Hiroshi Sakurai (Kanazawa University, Japan).
hsf1-R206S, F256Y cells and isogenic HSF1 cells were generously
gifted by Dr. Dennis Winge (University of Utah Health Sciences
Center, Salt Lake City, UT). ssa1-3 ssa2-2, ssa1-3 ssa2-2 hsf1P215Q
and isogenic wild type cells were obtained from Dr. Elizabeth
Craig (University of Wisconsin, Madison, WI). HSF1/HSF1 and
HSF1/hsf1D cells were obtained from Open Biosystems (www.
openbiosystems.com). FPR1, HYR1, GLN3 or Hsf1 target gene
deletions were made by PCR generation of a homology cassette
using a KanMX6 resistance module as a dominant marker. GAT1
deletion was made using URA3 as a dominant marker. All
disruptions were confirmed by PCR. To combine deletion of
msn2Dmsn4D with hsf1-R206S, F256S cells, YCP-TRP1-hsf1-R206S,
F256S plasmid was transformed into msn2Dmsn4D cells and the
wild type HSF1 plasmid was shuffled out using 5-FoA. Sensitivity
to rapamycin was determined by spotting serial dilutions of wild
type and mutant strains on minimal media or YPD plates
supplemented with rapamycin (dissolved in methanol) to a final
concentration of 10 nM or 25 nM. Media supplemented with
methanol alone were used for plates without rapamycin.
Sensitivity to cycloheximide was carried out identically on YPD
plates supplemented with cycloheximide at 0.025 mg/ml concen-
tration in DMSO or DMSO alone.
Sample preparation for proteomic analysis
BJ5465 cells were grown in liquid YPD that was either
supplemented with rapamycin at a final concentration of 200
nM (dissolved in methanol), or methanol alone. 70 minutes into
drug treatment, cells were collected and proteins extracted by
boiling in SDS sample buffer followed by vortexing in presence of
glass beads [84,85]. Extracted proteins were precipitated by TCA,
dissolved in 50mM Tris, 1%SDS, 5mM EDTA, and exchanged
into 50mM Hepes-KOH, pH7.5. 300 mg of protein from
rapamycin treated or control sample was trypsinized overnight
and labeled with
13C6-o r
12C6-versions of phenyl isocyanate (PIC)
essentially as described previously [23].
Peptide fractionationation and mass spectrometric
analysis
After labeling, samples were pooled, desalted and concentrated
using a mixed mode cation exchange (MCX) cartridge (Waters), and
fractionated by preparative isoelectric focusing using a Free Flow
Electrophoresis (FFE, BD Biosciences, Inc.) as described [24].
Immediately after FFE fractionation, the pH in each well of the
microtiter plate was measured using a micro pH electrode. Peptides
were resolved over a pH range of ,3–10. 10% of the sample was
removed from each well across the pH gradient, and subjected to
ultrafiltration to remove contaminating high molecular weight
HPMC polymer components of the ampholyte mixtures. The
filtrate was dried under vacuum and then loaded to a microcapillary
reverse-phase liquid chromatography (mLC) column and analyzed
online by automated tandem mass spectrometry (MS/MS) using a
Thermo-Fisher LTQ two-dimensional linear ion trap instrument.
Samples were automatically loaded across a Paradigm Platinum
Peptide Nanotrap (Michrom) pre-column (0.15 x 50 mm, 400 ml
volume) for sample concentrating and desalting, at a flow-rate of
50 ml/min in HPLC buffer A prior to loading into an inline
analytical capillary column (75 mm x 12 cm) with C18 resin (5 mm,
200Au Magic C18AG, Michrom) and Picofrit capillary tubing (New
Objective, Cambridge, MA). Peptides were eluted using a linear
gradient of 10–35% buffer B over 60 minutes, followed by isocratic
elutionat80%bufferBfor5 minuteswithaflowrateof0.25 ml/min
across the column. The electrospray voltage was set to 2.0 kV. A
data-dependent acquisition method was employed, in which each
full scan was followed by a high resolution zoom scan of each
precursorpeptide masspriortoMS/MSanalysis,inorderto provide
more accurate quantitative measurements of PIC labeled peptide
pairs. The four most intense precursor ions from each full scan were
selected for MS/MS. Selected precursor masses were excluded from
selection for MS/MS for 30 seconds. Each full scan consisted of 1
microscan with a maximum fill time of 50 milliseconds; each MS/
MS scan consisted of 1 microscan with a maximum fill time of 100
milliseconds.
Sequence Database Searching and Data analysis
All MS/MS data was analyzed by sequence database searching
using the program Sequest [86] against protein sequences derived
from all known open reading frames in S. cerevisiae. In order to
distinguish correct peptide matches from incorrect matches, we
used a combination of probability scores using the probabilistic
scoring algorithm, Peptide Prophet [87], and the difference
between predicted and observed isoelectric points of PIC labeled
peptides, essentially as described previously [24]. The charge on
the N-terminus of peptides was set to zero in theoretical pI
calculations due to the addition of the uncharged PIC group [23].
False positive rate of identification was estimated as described
before [88]. After pI filtering, a threshold Peptide Prophet
Hsf1 and TOR signaling
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an estimated false positive rate of 1%. Full scan mass spectra of
peptide sequence matches were inspected, the relative intensities of
light and heavy labeled peptide pairs measured, and relative
abundance ratios calculated (shown as C13/C12 ratios in
Supplementary Tables S1 and S2).
RNA isolation, real-time PCR analysis
HSF1, hsf1-R206S, F256S cells and strain derivatives were
grown in liquid YPD/minimal media at 25uCo r2 9 uC to log phase
prior to treatment with 200 nM rapamycin for 30 minutes. Total
cellular RNA was isolated using the Masterpure yeast RNA
purification kit (Epicentre) and reverse transcribed using the
iScript cDNA synthesis kit (Biorad). For real-time PCR analysis,
we used the LightCycler FastStart DNA MasterPlus SYBR Green
I kit (Roche) and a Roche Light Cycler 3.5 instrument. Cycle
thresholds for each gene were normalized to actin and the results
expressed as the fold induction with respect to untreated HSF1
cells. Statistical significance was determined by an unpaired, two-
tailed Student’s t-test assuming equal variance. Primer sequences
are listed in supplementary information, Table S3.
b-galactosidase assays and Western blotting
To monitor Hsf1 transcriptional activity, we transformed yeast
cells with a plasmid that expresses the HSE4Ptt-CYC1-LacZ
reporter. The latter consists of consensus heat shock elements
(nTTCnnGAAn)2 arranged in a tail-to-tail fashion and inserted
upstream of an attenuated CYC1 promoter that is fused to a LacZ
reporter gene [53,89]. b-galactosidase assays were performed
using the yeast b-galactosidase assay kit (Pierce, Cat. No. 75768)
and relative miller units of expression are shown graphed. For
western blotting against Tor1/2, from log phase cultures grown at
25uC, 5 OD600 units of cells were collected and proteins extracted
by boiling in SDS sample buffer followed by vortexing in presence
of glass beads [84,85]. Extracted proteins were precipitated by
TCA, dissolved in 50 mM Tris, pH7.5, 1% SDS and quantified by
BCA assay for protein concentration. Equal amounts of protein
were denatured using SDS-sample buffer and loaded on a 7.5%
SDS-PAGE gel. For obtaining extracts for monitoring Gln3-myc13,
log-phase cells were treated with rapamycin or methanol and flash
frozen. Cell pellets were lysed with glass beads and equal volume
of 20% TCA directly as described previously [90], and equal
amounts of protein loaded on a 6% SDS-PAGE gel. 12CA5
antibody was used for Gln3-myc13 detection; anti-Tor1 and Tor2
antibodies obtained from Santa Cruz Biotechnology Inc. were
used for detecting Tor1/2 using their recommended procedures.
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